Navigation Links
Two Hutchinson Center researchers named HHMI Early Career Scientists
Date:3/27/2009

SEATTLE The Howard Hughes Medical Research Institute today announced that two researchers at Fred Hutchinson Cancer Research Center are among 50 scientists nationwide to be appointed HHMI Early Career Scientists.

Harmit Singh Malik, Ph.D., an associate member of the Center's Basic Sciences Division, and Toshiyasu Taniguchi, M.D., Ph.D., an assistant member in the Center's Human Biology and Public Health Sciences divisions, each will receive a six-year appointment to the HHMI and, along with it, the freedom to explore his or her best ideas without worrying about where to find the money to fund the work. Each will receive $1.5 million over the six-year appointment. The Institute will also cover other expenses, including research space and the purchase of critical equipment.

"These scientists are at the early stage of their careers, when they are full of energy and not afraid to try something new," said Jack Dixon, HHMI vice president and chief scientific officer. "They have already demonstrated that they are not apt to play it safe and we hope they will continue to do something really original."

Malik, an evolutionary biologist, sees conflicts raging within a cell's nucleus as genes jockey for evolutionary dominance. These clashes can have a long-term impact on organisms, as they sometimes alter the function of essential genes. Malik uses biochemistry and genomics to study the causes and consequences of these genetic conflicts in yeast, fruit flies and other model organisms. His work has offered novel explanations for host-pathogen interactions and for the evolution of structural DNA elements (centromeres) that are critical for proper cell division. For example, to explore why humans are susceptible to HIV, Malik and his colleagues resurrected an extinct retrovirus that infected chimps and gorillas, but not humans, 4 million years ago. Malik's research suggests that we may be vulnerable to HIV infection because our defenses evolved to fight off other viruses instead. Recently, Malik and colleagues have shown that host proteins can evolve to defeat "viral mimicry," providing yet another nuance to a never-ending "arms race" between hosts and viruses.

Taniguchi, as a physician in Tokyo, treated many lymphoma patients with DNA-damaging chemotherapy, only to watch the drugs lose their power as the tumors developed resistance. He then became a researcher in cancer genetics to find ways to save more patients. At the Hutchinson Center, Taniguchi studies the role of DNA repair in promoting drug resistance in cancer cells. He identified a repair pathway that is often inactivated in patients with breast and ovarian cancers, as well as the childhood predisposition to cancer known as Fanconi anemia. Reactivation of the pathway, he discovered, can help tumors become resistant to chemotherapy drugs. Taniguchi intends to dig deeper into this mechanism of drug resistance and use the information he uncovers to develop drugs that will re-sensitize tumors to cancer therapies.

Malik and Taniguchi will begin their six-year, nonrenewable HHMI appointments in September 2009. The Institute anticipates another Early Career Scientist competition in 2012.


'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related biology news :

1. Uvalde Center water research could have national, international applications
2. NIH funds research center for womens reproductive health at Einstein
3. Stevens Center for Science Writings presents: Ravens at the Feast, with Bernd Heinrich, April 1
4. Bioscience institutions come together to launch Microlife Discovery Center for area students
5. Oceans journey towards the center of the Earth
6. Texas Obesity Research Center at UH assembles researchers to discuss obesity
7. Queens receives $9.1 million to establish National Center of Excellence in green chemistry
8. Public Policy Center hosts flood symposium March 10-12
9. NSF to fund water and environment technology center
10. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
11. Statement by the Egg Nutrition Center and American Egg Board on Diabetes Care study on egg consumption
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving air ... living in larger cities are affected by air pollution related diseases. , That is ... globally - decided to take action. , “I knew I had to take action ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology: